Latest FDA Stories
LONDON and SAN FRANCISCO, April 30, 2015 /PRNewswire/ -- GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc.
SEATTLE, April 30, 2015 /PRNewswire/ -- VUEMED announced today that it is partnering with
With the FDA and international regulatory bodies ramping up risk management requirements, and the potential for serious injury present in many medical devices experts say that Failure Modes and
Jerry Dalfors, the man the FDA asked to teach their own field inspectors about sterilization, will discuss the definition of “sterile” and how to get there.
OsteoRemedies®, LLC, today announced availability of the first FDA-approved modular system for two-staged
Attendees of the Medical Device Design Control workshop will have the opportunity to gain a greater understanding of the issues confronting them from Dan O’Leary, an expert in quality, operations
UDI deadlines are coming fast for all devicemakers and soon the FDA will demand compliance.
After returning to the U.S., Mahendra Kumar Trivedi and Trivedi Science™ announced their future collaboration with U.S.
Bernstein Liebhard LLP is representing testosterone lawsuit plaintiffs in the federal proceeding, which involves product liability claims filed over the alleged association between prescription
CYRAMZA Now Approved in the U.S.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.